TOPICAL NONSTEROIDAL ANTIINFLAMMATORY DRUGS FOR THE TREATMENT OF CYSTOID MACULAR EDEMA IN GYRATE ATROPHY
Gyrate atrophy is a rare genetic and progressive disorder affecting vision, due to ornithine aminotransferase (OAT) enzyme deficiency. This report describes a child with gyrate atrophy associated with bilateral cystoid macular edema (CME) at the time of diagnosis, confirmed by coherence tomography angiography (OCTA), which improved CME with topical non-steroid anti-inflammatory drug (NSAID).
A 6year-old girl complains of low visual acuity (best corrected VA was 20/60 in both eyes, refractive error: – 4.5D). Anterior segment was normal bilaterally. Dilated fundus examination revealed multiple bilateral, sharply defined, and scalloped chorioretinal atrophy areas in the midperipheral and peripheral zone. Spectral-domain optical coherence tomography (SD OCT) revealed bilateral CME in both eye and OCTA showed no sign of neovascularization. Serum ornithine level (990
The mechanism of the CME is still unclear. OCT examination is critical for diagnosing CME, even with a clinically normal macula. OCTA can help monitoring vascular changes in GA patients with a non-invasive imaging technique. It was seen that NSAIDs are effective to control CME, especially with the advantage of being a non-invasive treatment.
In this way, continued follow-up of these patients may provide further insights into the development of new and improved methods of treatment.
gyrate atrophy;cystoid macular edema;non-steroid anti-inflammatory drug;coherence tomography angiography
CLINICAL RETINA
SANTA CASA DE MISERICORDIA DE SAO PAULO - São Paulo - Brasil
NATASHA FERREIRA SANTOS DA CRUZ, JULIA DE LIMA FARAH, JULIANA MARIA FERRAZ SALLUM, MICHEL EID FARAH